Informed Melanoma Patients More Receptive to Internet Interventions

Share this content:
Patients receptive to an Internet-delivered behavioral intervention may already have higher knowledge of melanoma signs.
Patients receptive to an Internet-delivered behavioral intervention may already have higher knowledge of melanoma signs.

The melanoma patients receptive to an Internet-delivered behavioral intervention to promote skin self-examination (SSE) and sun protection behaviors may already have higher knowledge of melanoma signs, according to a research letter published in JAMA Dermatology.

Ashley K. Day, Ph.D., from Rutgers Cancer Institute of New Jersey, and colleagues examined factors associated with the receptivity of patients with melanoma (three to 24 months post-surgical treatment) to Internet-delivered interventions to promote engagement in SSEs and sun protection behaviors. Patients were randomly selected to participate, and 176 of 286 responded.

The researchers found that the majority of participants (84.1 percent) had Internet access, which was associated with being younger, having a higher educational level, and having greater knowledge of the ABCDE signs of melanoma.

RELATED: FDA Approves Nivolumab Plus Ipilimumab for Unresectable, Metastatic Melanoma

Over two-thirds of respondents (68.4 percent) indicated they were at least moderately interested in an Internet-delivered behavioral intervention. Similarly, those who were interested were likely to be younger, have greater knowledge of the ABCDE signs of melanoma, and be more comfortable using the Internet.

"This work highlights potential limitations of the reach of e-health interventions and identifies factors associated with the receptivity of patients with melanoma to such interventions," conclude the authors.

Reference

  1. Day AK, Stapelton JL, Manne SL, et al. Receptivity to Internet-Delivered Interventions to Promote Skin Self-examination and Sun Protection Behaviors in Patients With Melanoma. JAMA Dermatology. [published online ahead of print October 14, 2015]. doi:10.1001/jamadermatol.2015.2978.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters